Toward outcomes-based payments
Learn from industry leaders in this report from Reuters Events Pharma.
Related Content
Engage payers with value-based contracts
Assess the fit, develop metrics and track care outcomes over time.
Solve contract challenges for gene therapies
Gene therapies have the potential to be transformative, but there are hurdles to overcome for value-based contracts to become widespread.
How VBC can work for manufacturers
Value-based contracts can present challenges that must be overcome to bring gene therapies to market.